THE TAPE

Axogen, Inc. Common Stock

$55.38▼ −0.98%
Last close
Relative strength
95RS
of 99, against every stock▲ +12 on the month
Powering up
Unconfirmed
+31.8%
six months against the S&P 500
52-week range
−7.3%
from the high
$23.00$59.72
Setup
bull flagforming
−5.1%
against the pivot at $58.35
No report date on the calendar.
Growth REALProof PENDING
Quarter to Sep 30, revenue +26% on a year ago
11/16 O 55.56 H 56.35 L 55.00 Vol 1.2M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

RS95
vs pivot−5.09%
Tightening—
Dry-up—
Up/down vol0.08
From high7%
squatforming6 of 7checks
Previous breakout still open ▼ −5.54% in Nov
Powering up
Support and resistance
Support below
$50.86
-8.2% · tested 5× · last 12 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 0.6 weeks and fell 8% from its ceiling at its deepest. The pivot is $58.35, and the stock closed 5.1% below it. Its relative strength rating is 95.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+65.0%
Three months against the S&P 500
+14.4%
Six months against the S&P 500
+31.8%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 15.6% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$266.9M
+26.2% year on year
Operating margin
-5.2%
gross 74.2%
Net margin
-12.0%
Free cash flow
$22.0M
0.7% of market cap
Price to sales
12.4×
Price to earnings
—
not meaningful on a loss

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 28
Key takeaway
Growth with the cash to show for it: the quarter confirms the thesis.
Revenue
$75.8M
+8.8% QoQ · +26.2% YoY
Gross margin
74.8%
+2.1 pts QoQ
Net income
$2.3M
Positive
Free cash flow
$15.1M
Cash generating

What the numbers say

  • Good: Revenue +26.2% year over year, +8.8% on the quarter
  • Good: Gross margin 74.8%, +2.1 points on the quarter
  • Good: Profitable: net income $2M, operating margin 1.3%
  • Good: Cash generating: operating cash flow $17M, free cash flow $15M
  • Weak: Share count +25.3% in a year: dilution
  • Good: Net cash $329M · cash $329M
Revenue by quarter
Free cash flow
Net income
shares +25.3% in a year · net cash $328.9M

What is not obvious

  • Weak: Stock compensation $9M added back, 53% of operating cash flow; $8M after it
Final read
Growth: REAL · Economic proof: PENDING
Key question: Can the growth turn into durable profit and cash after its costs and financing?
The next test is funding the growth from operations: share count +25.3% in a year: dilution.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 1 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 trimmed.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
GappedTape · 2026-11-13
-5.5%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
New 52-week highTape · 2026-11-12
2.5x vol
Mixed: stocks have lagged random stocks by 0.9% over three sessions, not consistently enough to call (554 cases over 52 nights). Against their own sector they have lagged by 2.1%.
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-12
above 20d & 50d on 2.5x volume at 58.63
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
GappedTape · 2026-11-12
+15.2%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-11-06
-5.1%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Tightening after a sharp runTape · 2026-11-05
range halved after a +43% thrust, at 51.35
No measurable effect: stocks behave like random ones over the next three sessions (887 cases over 60 nights).
A new options position openedOPTIONS · 2026-10-30
2026-11-20 40C: OI +2,420 on 3,636 volume, ~$2.3M in calls (+2 more strikes)
Too few cases to judge yet (180 cases over 9 nights).
Reported resultsFiling · 2026-10-29
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
0
Sold on the open market
4
$4,657,286 total

Sold: TYNDALL JOSEPH A., Wendell Amy McBride, Began Marc A, Weiler Kathy Johnson.

Not counted above: 9 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-09-02 TYNDALL JOSEPH A. · Directorsell3,500$173,940
2026-08-11 Wendell Amy McBride · Directoroption exercise13,353$198,292
2026-08-11 Wendell Amy McBride · Directorsell13,353$646,592
2026-08-10 Began Marc A · EVP & General Counseloption exercise67,500$550,800
2026-08-10 Began Marc A · EVP & General Counselsell67,500$3,195,788
2026-08-07 Weiler Kathy Johnson · Directorsell14,150$640,967
2026-06-19 Levine Alan M · Directoroption exercise14,150
2026-06-19 Weiler Kathy Johnson · Directoroption exercise14,150

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

The geometry
bull flag
Level · ceiling$58.35
The pole · over 4 sessions+20.3%
Through to the apex72%
Touches · swing points the lines are drawn through3 up · 3 down
Length0.6 weeks
triangle
Level · ceiling$47.77
Wrong below$43.53
Measured target · the shape's own height$53.80
Reward against risk1.4×
Lines closed · of the gap they started with41%
Through to the apex41%
Touches · swing points the lines are drawn through13 up · 13 down
Length12.2 weeks
What lines up

6 of 7 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
More up-volume than down-volume
Within 15% of its 52-week high

2 checks are not listed because this stock has too little history to judge them — a 200-day average needs 200 sessions. They are left out of the total rather than counted as failures.

What analysts expect
Strong buy2
Buy9
Hold0
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray
11w · 36%

The most recent of 4 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Axogen, Inc. Common Stock (AXGN) — The Tape